Oncology / Radiation Therapy - Related Articles
Evaluation of a B-cell leukemia-lymphoma 2-specific radiolabeled peptide nucleic acid-peptide conjugate for scintigraphic detection of neoplastic lymphocytes in dogs with B-cell lymphoma
Kimberly A. Statham-Ringen, DVM, et al. AJVR, Vol 73, No 5, May 2012
A Randomized Trial Investigating the Efficacy and Safety of Water Soluble Micellar Paclitaxel (Paccal Vet) for Treatment of Nonresectable Grade 2 or 3 Mast Cell Tumors in Dogs
DM Vail, H von Euler, AW Rusk, L Barber, C Clifford, R Elmslie, et al. J Vet Intern Med, 2012 March: 1-10
R Elmslie, et al. Journal of Veterinary Internal Medicine September 1991, 5(5):283–293.
R Elmslie, et al. Veterinary Radiology November 1991, 32(6 ):277–280.
In vivo tumor transfection with super antigen plus cytokine genes induces tumor regression and pr longs survival in dogs with malignant melanoma.
SW Dow, R Elmslie, AP Willson, et al. J Clin Invest. June 1, 1998, 101(11): 2406-2414.
Intravenous cytokine gene delivery by lipid-DNA complexes controls the growth of established lung metastases.
SW Dow, R Elmslie, LG Fradkin, et al. Gene Therapy. December 1999, 10(18): 2961-2972.
Phase I study of liposome-DNA complexes encoding the interleukin-2 gene in dogs with osteosarcoma lung metastases
Steven Dow, R Elmslie, et al. HUMAN GENE THERAPY August 2005, 16:1-10.
Liposome–DNA complexes infused intravenously inhibit tumor angiogenesis and elicit antitumor activity in dogs with soft tissue sarcoma
D Kamstock, A Guth, R Elmslie, et al. Cancer Gene Therapy (2006) 13, 306–317.
B.J. Biller, R Elmslie, et al. Veterinary Immunology and Immunopathology 116 (2007) 69–78.
Doxorubicin and BAY 12–9566 for the Treatment of Osteosarcoma in Dogs: A Randomized, Double-Blind, Placebo-Controlled Study
Antony S. Moore, William S. Dernell GK Ogilvie, O Kristal, R Elmslie, et al. Journal of Veterinary Internal Medicine. July 2007, 21(4): 783–790.
LW U’Ren, BJ Biller, R Elmslie, et al. Journal of Veterinary Internal Medicine January 2007, 21(1), pages 113–120
S Lana, L U’Ren, S Plaza, R Elmslie, et al. Journal of Veterinary Internal Medicine July 2007, 21(4) :764–769
Metronomic Therapy with Cyclophosphamide and Piroxicam Effectively Delays Tumor Recurrence in Dogs with Incompletely Resected Soft Tissue Sarcomas
R Elmslie, et al. J Vet Intern Med 2008; 22:1373–1379.
D Kamstock, R Elmslie, et al., Cancer Immunology, 2007, 56 (8):1299-1309.
S Hafeman, C London, R Elmslie et al. Cancer Immunology, Immunotherapy March 2010, 59(3): 441-452.
Canine Lingual Lymphoma: A Retrospective Review of 8 Cases (2000-2010)
BM Twigg, CJ Henry, TA Rocha, R Elmslie, et al. Veterinary Cancer Society Proceedings Nov. 2010, San Diego, pp:67.
Molecular Imaging of the bcl-2 Oncogene in Canine B-Cell Lymphoma
Statham (Ringen) K, Green JA, Selting KA, Lattimer J, Bryan JN, Villamil JA, Henry CJ, Lewis MR. Proceedings of the 28th Veterinary Cancer Society Annual Conference, Seattle, WA, October 18-21 2008, 28.
Clinical Assessment of the Petscreen Proteomic Identification Profile for Canine Lymphoma
Villamil JA, Slater K, Statham (Ringen) K, Tyler J, Ratcliffe L, Shahid M, Mobasheri A, Henry CJ. Proceedings of the 28th Veterinary Cancer Society Annual Conference, Seattle, WA, October 18-21 2008, 11.
Comparison of Somatostatin Analogues and Conventional Imaging Modalities for Staging of Canine B-Cell Lymphoma
Ringen KS, Selting KA, Lattimer J, Bryan JN, Villamil JA, Henry CJ, Lewis MR. Proceedings of the 29th Veterinary Cancer Society Annual Conference, Austin, TX, October 16-19 2009, 13.
Molecular Imaging of Canine B-cell Lymphoma Using an Anti-bcl-2 Peptide Nucleic Acid-Peptide Conjugate
Ringen KS, Selting KA, Lattimer J, Bryan JN, Henry CJ, Green J, Jia F, Lewis MR. American Journal of Veterinary Research, (In press) 2011.